Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.90    0.00 (0.00%)
Bid:
1.80
Ask:
2.00
Spread: 0.20 (11.111%)
Market Cap: £8.30m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Director/PDMR Shareholding - Replacement

22 Jun 2021 13:25

RNS Number : 7366C
Renalytix AI PLC
22 June 2021
Β 

The following amendment(s) has been made to the ' Director/PDMR Dealing' announcement released on 22 June 2021 at 10:57 under RNS No 7062C.

Β 

The price of 113.5 pence per share was incorrect and has been amended to 1135 pence per share.

The Company was also informed of the sale 'yesterday'.

Β 

All other details remain unchanged.

Β 

The full amended text is shown below.

Β 

Renalytix AI plcΒ 

Β 

("Renalytix" or the "Company")

Β 

Director/PDMR Dealing

Β 

The Company was informed that yesterday, Christopher Mills, a non-executive director and interim Chairman, completed the sale of 17,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 1135 pence per share.

Β 

Following completion of the sale, Christopher Mills is interested inΒ 9,180,501 Ordinary Shares representing 12.74% of the current issued share capital of the Company.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Β 

Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited as investment manager to North Atlantic Smaller Companies Investment Trust plc and Oryx

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Christopher Mills, non-exec director and Interim Chair of the issuer and director of NASCIT and Oryx International Growth Fund Ltd

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Renalytix AI plc

b)

Β 

LEI

Β 

Β 

213800NTOH3FK3WER551

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of Β£0.0025 each

Identification code

GB00BYWL4Y04

Β 

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale of shares

c)

Currency

GBP

d)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Β 

Price(s)

Volume(s)

Β 

Β 

Β£11.352941

17,000

Β 

Β 

Β 

Β 

Β 

e)

Β 

Aggregated information

- Aggregated volume

17,000

- Price

Β£192,999.99

f)

Β 

Date of the transaction

Β 

Β 

18 June 2021

g)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHZZGZVZZFGMZM
Date   Source Headline
12th Apr 20247:00 amRNSRule 2.9 Announcement
10th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
10th Apr 202410:00 amRNSIssue of Shares
9th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
9th Apr 20247:24 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Apr 20247:50 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
8th Apr 20247:44 amRNSFinancing with Expected Size of up to $4 Million
5th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Apr 202411:39 amRNSChange of Registered Address
4th Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
4th Apr 20247:31 amGNWForm 8.5 (EPT/RI) - Renalytix plc
3rd Apr 20243:02 pmRNSNotice of GM
3rd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Apr 20247:46 amGNWForm 8.5 (EPT/RI) - Renalytix plc
2nd Apr 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
28th Mar 20245:07 pmRNSForm 8.3 - Renalytix plc
28th Mar 20242:52 pmRNSHolding(s) in Company
28th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
27th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
26th Mar 20243:14 pmRNSHolding(s) in Company
26th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
26th Mar 20247:54 amGNWForm 8.5 (EPT/RI) - Renalytix plc
25th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
22nd Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
22nd Mar 20248:37 amGNWForm 8.5 (EPT/RI) - Renalytix plc
21st Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
21st Mar 20247:00 amRNSForm 8.3 - Renalytix Plc
21st Mar 20246:45 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
20th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
20th Mar 20247:29 amGNWForm 8.5 (EPT/RI) - Renalytix plc
19th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
18th Mar 20244:18 pmRNSForm 8.3 - Renalytix Plc - Replacement
18th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
18th Mar 202411:54 amRNSForm 8.3 - Renalytix Plc
18th Mar 202410:27 amRNSForm 8.3 - Renalytix Plc
18th Mar 20247:56 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
15th Mar 20243:20 pmPRNForm 8.3 - Renalytix Plc
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 20242:55 pmRNSForm 8.3 - Renalytix plc
15th Mar 20242:42 pmRNSForm 8.3 - Renalytix plc
15th Mar 20241:36 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202412:05 pmRNSForm 8 (DD) - Renalytix Plc
15th Mar 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
15th Mar 20247:27 amGNWForm 8.5 (EPT/RI) - Renalytix plc
15th Mar 20247:00 amRNSRule 2.9 announcement
14th Mar 20244:38 pmPRNForm 8.3 - Renalytix Plc
14th Mar 20244:03 pmPRNForm 8.3 - Renalytix Plc
14th Mar 20243:38 pmRNSForm 8 (DD) - Renalytix Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.